What evidence is there for exersice oncology, what clinical trials have been discussed by people in this field

May 27, 2026Navis AI

Ask Navis about your situation

This answer is general. Get one about your specific case — no signup, answered right here.

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Sources & medical oversight

  • Developed under the medical oversight of OpenCancer’s physician-scientist team (Chris Apfel, MD/PhD/MBA, CMO · Kaumudi Bhawe, PhD, CSO).
  • Last updated May 27, 2026. Informational only — not a substitute for your oncology team.

Exercise Oncology: Evidence and Clinical Trials

Exercise oncology is a growing field with substantial clinical evidence supporting its benefits for cancer patients. Let me break down what the research shows and highlight key clinical trials.

Current Evidence Base

Physical activity during and after cancer treatment has demonstrated benefits including:

  • Improved cancer-related fatigue - One of the most consistent findings across studies
  • Better physical function and strength - Particularly important during treatment
  • Enhanced quality of life - Psychological and emotional benefits documented
  • Reduced treatment side effects - Including cardiotoxicity from certain chemotherapies
  • Potential survival benefits - Some studies suggest improved outcomes, though this remains an active research area
  • Cardiovascular health - Important given cancer treatment can affect heart function
  • Mental health improvements - Reduced anxiety and depression symptoms

According to the American Cancer Society, physical activity is recommended for cancer survivors, with guidelines suggesting 150 minutes of moderate-intensity aerobic activity per week, combined with resistance training 2+ days per week.

Major Clinical Trials & Research Initiatives

Key trials discussed in the exercise oncology field include:

  1. CHALLENGE Trial - Examined exercise interventions during chemotherapy for breast cancer, showing improvements in physical function and fatigue management

  2. CARE Trial - Focused on cardiac rehabilitation and exercise for cancer survivors, particularly those at risk for heart problems from treatment

  3. LIVESTRONG at the YMCA - Large-scale community program with documented outcomes in cancer survivor fitness and quality of life

  4. Exercise and Nutrition Enhance Recovery (ENER) - Multiple studies examining combined interventions

  5. Breast Cancer and Exercise Trial (BEAT) - Investigated supervised exercise during active treatment

  6. Prostate Cancer and Exercise (PACE) - Examined exercise benefits for prostate cancer patients

What ASCO and NCI Say

The American Society of Clinical Oncology (ASCO) has increasingly incorporated exercise recommendations into survivorship guidelines, recognizing it as a standard component of cancer care.

The National Cancer Institute (NCI) supports exercise oncology research and has documented that exercise can help manage treatment side effects and improve long-term outcomes.

Current Research Gaps & Active Questions

Researchers are actively investigating:

  • Optimal exercise prescriptions - What type, intensity, and duration work best for different cancer types?
  • Timing of interventions - When during treatment is exercise most beneficial?
  • Mechanisms of benefit - How does exercise improve outcomes at a biological level?
  • Underserved populations - How to reach patients with limited access to programs?
  • Long-term survival impact - Ongoing studies examining whether exercise improves overall survival

Practical Implementation

Many cancer centers now employ exercise physiologists or oncology-trained fitness specialists as part of the care team. Programs like those endorsed by the American Cancer Society provide structured, evidence-based exercise guidance.


This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Ask Navis about your case

That answer is general. Ask about your specific situation — no signup, answered right here.

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →

Related Services

Services that may help with clinical trials for cancer patients

Related Questions

Prostate cancer, Gleason 6. Is active surveillance reasonable

TL;DR: Gleason 6 prostate cancer is generally considered low-risk, and active surveillance careful monitoring without immediate treatment is a reasona

What staging questions should I ask

TL;DR: Staging questions help your doctor understand how far your follicular lymphoma has spread, which directly determines your treatment options and

Just diagnosed with follicular lymphoma. What should I ask my oncologist

TL;DR: Follicular lymphoma is highly treatable, and your first conversation with your oncologist should focus on understanding your specific stage, wh

Prostate cancer, Gleason 6. Is active surveillance reasonable for me

TL;DR: Gleason 6 prostate cancer is generally considered low-risk, and active surveillance careful monitoring without immediate treatment is a reasona

What questions about staging should I bring up

TL;DR: Staging tells you how advanced your cancer is and helps your doctor plan treatment—ask your team to explain YOUR specific stage and what it mea

Just diagnosed with follicular lymphoma. What should I ask my oncologist at my first appointment

TL;DR: Your first appointment is about understanding your specific type of follicular lymphoma and what tests you need—ask your doctor what stage you

What lifestyle changes are recommended for cancer patients

TL;DR: Lifestyle changes like nutrition, exercise, sleep, and stress management can help support your body during cancer treatment and improve how you

What is the drug for fgfr mytation

Several FDA-approved drugs target FGFR mutations, with pemigatinib and infigratinib being the most commonly used; your doctor will choose based on you